Effects of shallomin and podophyllin solution 25% for genital HPV warts in women: a randomized controlled trial

被引:5
|
作者
Shahali, Shadab [1 ]
Amin, Mansour [2 ,3 ]
Hassani, Masoumeh Khajeh [4 ]
Yaghoobi, Reza [5 ]
Saki, Morteza [3 ,6 ]
机构
[1] Tarbiat Modares Univ, Fac Med Sci, Dept Reprod Hlth & Midwifery, Tehran, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Hlth Res Inst, Infect & Trop Dis Res Ctr, Ahvaz, Iran
[3] Ahvaz Jundishapur Univ Med Sci, Fac Med, Dept Microbiol, Golestan St, Ahvaz, Iran
[4] Ahvaz Jundishapur Univ Med Sci, Reprod Hlth Promot Res Ctr, Dept Midwifery, Ahvaz, Iran
[5] Ahvaz Jundishapur Univ Med Sci, Dept Dermatol, Ahvaz, Iran
[6] Ahvaz Jundishapur Univ Med Sci, Student Res Comm, Ahvaz, Iran
关键词
Podophyllin; Genital wart; Human papillomavirus; ALLIUM-HIRTIFOLIUM; PERSIAN SHALLOT;
D O I
10.4103/2221-6189.259111
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To compare the effect of shallomin (pure fraction of Allium hirtifolium) with podophyllin 25% solution on external genital human papillomavirus warts in women. Methods: This study was a randomized controlled trial which was performed on two groups of 25 Iranian women with external genital warts at Imam Khomeini Hospital in Ahvaz, Iran. In the first group, shallomin was used once a day for six weeks at home. In the second group, 25% podophyllin solution, was applied on the lesion once weekly for six weeks. Results: Shallomin and podophyllin resulted in wart clearance in 13/23 (56.5%), and 12/24 (50%) of patients, respectively. The clearance rate for shallomin was not significantly different from that of podophyllin (P=0.082). Six weeks after the treatment, the sizes of the lesions in the shallomin group and the podophyllin group decreased by (1.43 +/- 0.53) mm and (1.64 +/- 0.70) mm, respectively. Conclusion: Shallomin is an effective treatment for genital warts, with similar efficacy to that of podophyllin.
引用
收藏
页码:118 / 122
页数:5
相关论文
共 50 条
  • [21] Nowarta110 Topical Versus Placebo for the Treatment of Plantar Warts: A Phase I/II Randomized Controlled Clinical Trial
    Yousefpour, Mahkameh
    Zamanian, Iraj
    Akbarpour, Ferre
    Fang, William H.
    Han, Bo
    Hoang, Ba X.
    ANTICANCER RESEARCH, 2023, 43 (05) : 2025 - 2030
  • [22] Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial
    Barnabas, Ruanne, V
    Brown, Elizabeth R.
    Onono, Maricianah
    Bukusi, Elizabeth A.
    Njoroge, Betty
    Winer, Rachel L.
    Donnell, Deborah
    Galloway, Denise
    Cherne, Stephen
    Heller, Kate
    Leingang, Hannah
    Morrison, Susan
    Rechkina, Elena
    McClelland, R. Scott
    Baeten, Jared M.
    Celum, Connie
    Mugo, Nelly
    TRIALS, 2021, 22 (01)
  • [23] Single-dose HPV vaccination efficacy among adolescent girls and young women in Kenya (the KEN SHE Study): study protocol for a randomized controlled trial
    Ruanne V. Barnabas
    Elizabeth R. Brown
    Maricianah Onono
    Elizabeth A. Bukusi
    Betty Njoroge
    Rachel L. Winer
    Deborah Donnell
    Denise Galloway
    Stephen Cherne
    Kate Heller
    Hannah Leingang
    Susan Morrison
    Elena Rechkina
    R. Scott McClelland
    Jared M. Baeten
    Connie Celum
    Nelly Mugo
    Trials, 22
  • [24] Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
    Karl Ulrich Petry
    Alexander Luyten
    Annika Justus
    Angelika Iftner
    Sarah Strehlke
    Renate Schulze-Rath
    Thomas Iftner
    BMC Infectious Diseases, 12
  • [25] Safety and Immunogenicity of the HPV-16/18 AS04-Adjuvanted Vaccine: A Randomized, Controlled Trial in Adolescent Girls
    Medina, Doris M. Rivera
    Valencia, Alejandra
    de Velasquez, Alet
    Huang, Li-Min
    Prymula, Roman
    Garcia-Sicilia, Jose
    Rombo, Lars
    David, Marie Pierre P.
    Descamps, Dominique
    Hardt, Karin
    Dubin, Gary
    JOURNAL OF ADOLESCENT HEALTH, 2010, 46 (05) : 414 - 421
  • [26] Parent report of provider HPV vaccine communication strategies used during a randomized, controlled trial of a provider communication intervention
    Dempsey, A. F.
    Pyrzanowski, J.
    Campagna, E. J.
    Lockhart, S.
    O'Leary, S. T.
    VACCINE, 2019, 37 (10) : 1307 - 1312
  • [27] HPV Self-Sampling for Cervical Cancer Screening Among Ethnic Minority Women in South Florida: a Randomized Trial
    Carrasquillo, Olveen
    Seay, Julia
    Amofah, Anthony
    Pierre, Larry
    Alonzo, Yisel
    McCann, Shelia
    Gonzalez, Martha
    Trevil, Dinah
    Koru-Sengul, Tulay
    Kobetz, Erin
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (07) : 1077 - 1083
  • [28] A Comparative Study of the Efficacy of Intralesional Measles Mumps Rubella (MMR) Vaccine and Auto Implantation for the Treatment of Periungual and Palmoplantar Warts: A Randomized Controlled Trial
    Abusaria, Ravindra
    Yadav, Chinmai
    Jain, Vinod
    Kachhawa, Dilip
    Rao, Pankaj
    Lamoria, Anand
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2024, 15 (05) : 812 - 816
  • [29] Effects of a randomized controlled trial of a brief, student-nurse led, parent-based sexual health intervention on parental protective factors and HPV vaccination uptake
    D. Santa Maria
    C. Markham
    S. M. Misra
    D. C. Coleman
    M. Lyons
    C. Desormeaux
    S. Cron
    V. Guilamo-Ramos
    BMC Public Health, 21
  • [30] MANAGEMENT OF GENITAL WARTS IN WOMEN WITH HUMAN-LEUKOCYTE INTERFERON-ALPHA VS PODOPHYLLOTOXIN IN CREAM - A PLACEBO-CONTROLLED, DOUBLE-BLIND, COMPARATIVE-STUDY
    SYED, TA
    KHAYYAMI, M
    KRIZ, D
    SVANBERG, K
    KAHLON, RC
    AHMAD, SA
    AHMAD, SA
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1995, 73 (05): : 255 - 258